029 GROUP SE INH O.N.

Z29 XETRA Healthcare & Biotech Germany
40.60

German company specialized in the healthcare sector, focused on care and medical services.

Performance & Momentum

6 Months 40.97 %
1 Year 6.28 %
3 Years 227.42 %
5 Years 401.23 %

Strategic Analysis

029 Group SE positions itself as a German player specializing in medical care and services, integrating innovative medical to meet the growing needs of an aging population. Its model combines clinical expertise and digitalization of services, giving it a differentiated niche in the specialized healthcare market.

Strengths
  • Strong foothold in Germany’s specialized healthcare sector, a dynamic and growing market
  • Technological innovation capability in medical services, helping improve care efficiency
  • Solid long-term performance, reflecting a sustainable strategy and rising valuation
Weaknesses
  • Recent medium-term underperformance may reflect operational or cyclical challenges
  • Lack of recent announcements limiting visibility on future developments
Momentum

Despite a favorable momentum, the stock has experienced a recent correction over the past 6 and 12 months, suggesting a consolidation phase after sustained long-term growth. This dynamic calls for caution but also opens an opportunity window for patient investors, provided that operational prospects and ongoing innovation are closely monitored.

Similar stocks to 029 GROUP SE INH O.N.

Anantys Community

Be the first to share your analysis on 029 GROUP SE INH O.N..

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases